A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
Clinical trial NCT06413654 · RECRUITING
Trial details
- NCT number
- NCT06413654
- Sponsor
- Shanghai Jiaolian Drug Research and Development Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-17
- Primary completion
- 2027-10-31
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.